Filana Therapeutics (FRA:PX91) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PX91 Filana Therapeutics Inc FRA:PX91
26 GF Score
Price €0.77
! 2 Warning Signs
View Full Analysis

What is Filana Therapeutics SpecialCharges?

Special Charges only applies to banks.

FRA:PX91
26GF Score
Filana Therapeutics Inc FRA:PX91
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Filana Therapeutics Business Description

Other Exchanges FLNA:USAFLNA:Mexico
Address 6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
26GF Score

Get the complete analysis for FRA:PX91

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.77
Price